Development of a multi-miRNA detection platform for enhanced diagnostics of colorectal cancer
Biosensors and Bioelectronics · 2025-11 · 287 · 117639
DOI: 10.1016/j.bios.2025.117639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-11. Verfasst von Bo Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs, Biosensing Techniques, Biomarkers, Tumor. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: The Startup Fund from Shenzhen Bay Laboratory, Development and Reform Commission of Shenzhen Municipality, Shenzhen Bay Laboratory.
Abstract (Originalsprache)
The identification of specific miRNA biomarkers has considerably advanced colorectal cancer (CRC) diagnostics. Our prior research identified four key miRNA signatures-miR-10b-5p, miR-130a-3p, miR-561-5p, and miR-4684-5p-as potential diagnostic markers for CRC. To enhance the clinical utility of these biomarkers, we developed a novel multi-miRNA detection platform, RCA-SDA-CRISPR (RS-CRISPR), which integrates rolling circle amplification (RCA), strand displacement amplification (SDA), and CRISPR/Cas12a technologies. This platform employs RCA products as SDA templates, maximizes miRNA binding sites, and utilizes the spatial arrangement of miRNAs to bypass limitations of traditional enzymatic cleavage, enabling rapid, simultaneous detection of multiple miRNAs. RS-CRISPR achieved a detection sensitivity of 57.8fM for target miRNAs. In clinical validation, this method successfully distinguished tumor tissue from adjacent non-cancerous tissue in five patients with CRC. In addition, during the serum analysis of 12 normal controls (NC) and 12 CRC patients, we found that the levels of four specific miRNAs were significantly higher in CRC patients compared to NC (p = 0.00646), underscoring its diagnostic potential. These findings establish RS-CRISPR as a promising, precise, and efficient diagnostic tool for clinical CRC management through multi-miRNA detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China.
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
- State Key Laboratory of Chemical Oncogenomics, Tsinghua Shenzhen International Graduate School, Shenzhen, 518055, China.
- School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China. Electronic address: chenyan@szu.edu.cn.
- School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China; State Ke…
Förderung
- The Startup Fund from Shenzhen Bay Laboratory
- Development and Reform Commission of Shenzhen Municipality
- Shenzhen Bay Laboratory
- Shenzhen University
- The Startup Fund from Shenzhen University
Zitieren
APA
Zhou, B., Fan, T., Chen, H., Huang, Y., Lai, X., Feng, S., Ding, Z., Chen, Y., & Jiang, Y. (2025). Development of a multi-miRNA detection platform for enhanced diagnostics of colorectal cancer. Biosensors and Bioelectronics, 287, 117639. https://doi.org/10.1016/j.bios.2025.117639
Vancouver
Zhou B, Fan T, Chen H, Huang Y, Lai X, Feng S, et al. Development of a multi-miRNA detection platform for enhanced diagnostics of colorectal cancer. Biosensors and Bioelectronics. 2025;287:117639. doi:10.1016/j.bios.2025.117639
BibTeX
@article{Zhou2025,
author = {Zhou, Bo and Fan, Tingting and Chen, Hui and Huang, Yiming and Lai, Xinjie and Feng, Shanshan and Ding, Zijian and Chen, Yan and Jiang, Yuyang},
title = {Development of a multi-miRNA detection platform for enhanced diagnostics of colorectal cancer},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {287},
pages = {117639},
doi = {10.1016/j.bios.2025.117639}
}
EUVIMED